{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:59:08Z","timestamp":1790773148214,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.jbspin.2026.106131","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:00:40Z","timestamp":1788278440000},"page":"106131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Residual activated Th17 cells during low disease activity are associated with disease worsening in radiographic axial spondyloarthritis: A pilot study"],"prefix":"10.1016","volume":"94","author":[{"given":"Oh Chan","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lark Kyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1189-7637","authenticated-orcid":false,"given":"Min-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2026.106131_bib0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(24)02263-3","article-title":"Axial spondyloarthritis","volume":"405","author":"Navarro-Comp\u00e1n","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2026.106131_bib0135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.2024.20917","article-title":"Axial spondyloarthritis: a review","volume":"333","author":"Bittar","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2026.106131_bib0140","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106131_bib0145","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","article-title":"High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort","volume":"75","author":"Poddubnyy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106131_bib0150","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.41667","article-title":"Tumor necrosis factor inhibitors reduce spinal radiographic progression in patients with radiographic axial spondyloarthritis: a longitudinal analysis from the Alberta prospective cohort","volume":"73","author":"Sepriano","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","article-title":"TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106131_bib0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13075-021-02695-5","article-title":"Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO","volume":"24","author":"Llop","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2026.106131_bib0165","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/art.24103","article-title":"Living with a fluctuating illness of ankylosing spondylitis: a qualitative study","volume":"59","author":"Mengshoel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106131_bib0170","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/rheumatology\/kew303","article-title":"Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis","volume":"55","author":"Essers","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2026.106131_bib0175","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2026.106131_bib0180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3899\/jrheum.200934","article-title":"Residual disease burden in patients with axial spondyloarthritis and psoriatic arthritis despite low disease activity states in a multiethnic Asian population","volume":"48","author":"Liu","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106131_bib0190","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106131_bib0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106131_bib0200","doi-asserted-by":"crossref","first-page":"152781","DOI":"10.1016\/j.semarthrit.2025.152781","article-title":"The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: are ASAS recommendations being followed?","volume":"74","author":"Santos","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106131_bib0205","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/rheumatology\/keaf089","article-title":"The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs","volume":"64","author":"Zhao","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2026.106131_bib0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4078\/jrd.2024.0029","article-title":"The effectiveness of tumor necrosis factor-\u03b1 blocker therapy in patients with axial spondyloarthritis who failed conventional treatment: a comparative study focused on improvement in ASAS Health Index","volume":"31","author":"Choi","year":"2024","journal-title":"J Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106131_bib0215","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","article-title":"IL-17 in the immunopathogenesis of spondyloarthritis","volume":"14","author":"Taams","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0225","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.2854","article-title":"Primed for inflammation: enthesis-resident T cells","volume":"18","author":"Lories","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2026.106131_bib0230","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/BOR.0000000000000069","article-title":"The interleukin-23\/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis","volume":"26","author":"Yeremenko","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0235","doi-asserted-by":"crossref","first-page":"696973","DOI":"10.3389\/fimmu.2021.696973","article-title":"Imbalance of peripheral lymphocyte subsets in patients with ankylosing spondylitis: a meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0245","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3389\/fimmu.2018.01610","article-title":"Increased IL-22- and IL-17A-producing mucosal-associated invariant T cells in the peripheral blood of patients with ankylosing spondylitis","volume":"9","author":"Toussirot","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2026.106131_bib0250","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ard.2025.04.018","article-title":"CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in spondyloarthritis synovial tissue","volume":"84","author":"Liu","year":"2025","journal-title":"Ann Rheum Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:19:38Z","timestamp":1790770778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X26001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2027,3]]}},"alternative-id":["S1297319X26001004"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106131","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual activated Th17 cells during low disease activity are associated with disease worsening in radiographic axial spondyloarthritis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106131"}}